Siegfried Reich insider trades: Turning Point Therapeutics (TPTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Siegfried reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | TPTX | ↓ Sell | 397 | $36.30 | $14K | Direct | Feb 11, 2022 (2d) |
| Mar 4, 2021 | TPTX | ↓ Sell | 35,550 | $105.04 | $3.7M | Direct | Mar 5, 2021 (1d) |
| Aug 15, 2008 | SGXP | ↓ Sell | 781 | $2.98 | $2K | Direct | Aug 18, 2008 (3d) |
| Jul 15, 2008 | SGXP | ↓ Sell | 781 | $3.05 | $2K | Direct | Jul 16, 2008 (1d) |
| Jun 16, 2008 | SGXP | ↓ Sell | 781 | $1.65 | $1K | Direct | Jun 17, 2008 (1d) |
| May 15, 2008 | SGXP | ↓ Sell | 781 | $1.45 | $1K | Direct | May 15, 2008 (0d) |
| Apr 15, 2008 | SGXP | ↓ Sell | 781 | $1.19 | $929 | Direct | Apr 16, 2008 (1d) |
| Mar 17, 2008 | SGXP | ↓ Sell | 781 | $4.01 | $3K | Direct | Mar 18, 2008 (1d) |
| Feb 15, 2008 | SGXP | ↓ Sell | 781 | $4.05 | $3K | Direct | Feb 19, 2008 (4d) |
| Jan 15, 2008 | SGXP | ↓ Sell | 781 | $4.44 | $3K | Direct | Jan 16, 2008 (1d) |
| Dec 17, 2007 | SGXP | ↓ Sell | 781 | $4.75 | $4K | Direct | Dec 18, 2007 (1d) |
| Nov 15, 2007 | SGXP | ↓ Sell | 781 | $5.10 | $4K | Direct | Nov 16, 2007 (1d) |
| Oct 15, 2007 | SGXP | ↓ Sell | 781 | $6.42 | $5K | Direct | Oct 15, 2007 (0d) |
| Sep 17, 2007 | SGXP | ↓ Sell | 781 | $6.20 | $5K | Direct | Sep 17, 2007 (0d) |
| Aug 15, 2007 | SGXP | ↓ Sell | 781 | $6.41 | $5K | Direct | Aug 16, 2007 (1d) |
| Jul 16, 2007 | SGXP | ↓ Sell | 781 | $6.05 | $5K | Direct | Jul 16, 2007 (0d) |
| Jun 15, 2007 | SGXP | ↓ Sell | 781 | $5.12 | $4K | Direct | Jun 19, 2007 (4d) |
| May 15, 2007 | SGXP | ↓ Sell | 781 | $5.18 | $4K | Direct | May 16, 2007 (1d) |
| Apr 16, 2007 | SGXP | ↓ Sell | 781 | $5.02 | $4K | Direct | Apr 17, 2007 (1d) |
| Mar 15, 2007 | SGXP | ↓ Sell | 781 | $5.53 | $4K | Direct | Mar 15, 2007 (0d) |
| Feb 15, 2007 | SGXP | ↓ Sell | 781 | $5.36 | $4K | Direct | Feb 15, 2007 (0d) |
| Jan 16, 2007 | SGXP | ↓ Sell | 9,375 | $3.50 | $33K | Direct | Jan 16, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Siegfried Reich's insider trades
Siegfried Reich is EVP & Chief Scientific Officer at Turning Point Therapeutics (TPTX). Since Jan 16, 2007, Siegfried has reported no open-market purchases and 22 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (21 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TPTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.